<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T13:11:59Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/220936" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/220936</identifier><datestamp>2025-12-05T15:55:50Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478860</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Association between routine blood biomarkers and clinical phenotypes and exacerbations in chronic obstructive pulmonary disease</dc:title>
   <dc:creator>Nuñez, Alexa</dc:creator>
   <dc:creator>Marras, Viviana</dc:creator>
   <dc:creator>Harlander, Matevz</dc:creator>
   <dc:creator>Mekov, Evgeni</dc:creator>
   <dc:creator>Esquinas López, Cristina</dc:creator>
   <dc:creator>Turel, Matjaz</dc:creator>
   <dc:creator>Lestan, David</dc:creator>
   <dc:creator>Petkov, Rosen</dc:creator>
   <dc:creator>Yanev, Nikolay</dc:creator>
   <dc:creator>Pirina, Pietro</dc:creator>
   <dc:creator>Negri, Silvia</dc:creator>
   <dc:creator>Miravitlles Fernández, Marc</dc:creator>
   <dc:creator>Barrecheguren, Miriam</dc:creator>
   <dc:subject>Marcadors bioquímics</dc:subject>
   <dc:subject>Malalties pulmonars obstructives cròniques</dc:subject>
   <dc:subject>Fenotip</dc:subject>
   <dc:subject>Biochemical markers</dc:subject>
   <dc:subject>Chronic obstructive pulmonary diseases</dc:subject>
   <dc:subject>Phenotype</dc:subject>
   <dcterms:abstract>Introduction: Chronic obstructive pulmonary disease (COPD) is associated with increased lung and systemic inflammation. We aimed to identify associations between easy-to-obtain blood biomarkers and the frequency and severity of exacerbations. Methods: Cross-sectional, multicentre study performed in four centres in Spain, Italy, Bulgaria, and Slovenia. Blood samples were obtained for blood cell count, C-reactive protein (CRP), alpha-1 antitrypsin (AAT) and fibrinogen analysis. The neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) and eosinophil/basophil ratio (EBR) were calculated. Firstly, patients were divided into clinical phenotypes according to the Spanish guidelines of COPD, and secondly, patients were classified into 2 groups: non-exacerbators (≤1 ambulatory exacerbation in the previous year) and exacerbators (≥2 ambulatory exacerbations or 1 hospitalisation in the previous year). A multivariate stepwise logistic regression model was performed to identify laboratory parameters associated with exacerbators. Results: A total of 355 patients with a mean age 66 years (SD=8.9) were included, and 64% were male. The mean FEV1% (forced expiratory volume in the first second) was 55% (SD=20%), and the mean COPD Assessment Test (CAT) score was 15.6 (SD=7.9). One hundred ninety-six (55.2%) patients were classified in the non-exacerbator group, and 159 (44.8%) were exacerbators. Patients in the exacerbators group presented lower haemoglobin levels (p=0.019) and ERB (p= 0.023) but higher CRP levels (p=0.001). In the multivariate analysis, females, higher levels of CRP, lower FEV1% and low EBR were independently related to exacerbators.&#xd;
Conclusion: Female sex, having a more severe impairment of lung function, higher CRP levels and a lower EBR are associated with an exacerbator phenotype in COPD.</dcterms:abstract>
   <dcterms:issued>2025-05-09T17:46:50Z</dcterms:issued>
   <dcterms:issued>2025-05-09T17:46:50Z</dcterms:issued>
   <dcterms:issued>2020-03-31</dcterms:issued>
   <dcterms:issued>2025-05-09T17:46:50Z</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:relation>Reproducció del document publicat a: https://doi.org/10.2147/COPD.S240720</dc:relation>
   <dc:relation>International Journal of Chronic Obstructive Pulmonary Disease, 2020, vol. 15, p. 681-690</dc:relation>
   <dc:relation>https://doi.org/10.2147/COPD.S240720</dc:relation>
   <dc:rights>cc-by-nc (c)  Nuñez, Alexa et al., 2020</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>Dove Medical Press</dc:publisher>
   <dc:source>Articles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil)</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>